Scholarlink

Background <p>Chronic low-grade inflammation is often seen in individuals with insulin resistance, characterised by increased levels of pro-inflammatory cytokines, such as TNF-α (tumour necrosis factor-alpha) and IL-6 (interleukin-6). Insulin resistance (IR) and vitamin D deficiency are increasingly recognised as interconnected metabolic issues. Research indicated that low vitamin D levels may impair insulin sensitivity, while insulin resistance can worsen vitamin D deficiency, creating a vicious cycle. This study aims to explore the relationship between TNF-α and IL-6 expression levels and vitamin D levels in insulin-resistant patients with type 2 diabetes mellitus (DM), and compare them with non-diabetic controls to better understand the role of vitamin D in inflammation, disease development, and progression.</p> Methods <p>From a total of 150 participants, 30 were healthy individuals (the control group), and 120 were patients with type II diabetes. The current case-control study compared TNF-α, IL-6 expression levels, and serum vitamin D levels between insulin-resistant patients and non-diabetic controls.</p> Results <p>The demographic and clinical variables were statistically significant. The case-to-control ratio was 4:1. Higher levels of TNF-α and IL-6 were found in DM patients compared to non-diabetic controls. Insulin-resistant patients exhibited higher IL-6 levels (5.47 ± 0.30 pg/ml) than healthy participants (2.64 ± 0.83 pg/ml), with <i>p</i>-value &lt; 0.001. Vitamin D levels were significantly lower in DM patients (22.33 ± 11.43 ng/ml) compared to healthy subjects (34.12 ± 2.08 ng/ml), with <i>p</i>-value &lt; 0.001. TNF-α levels were also significantly higher in DM patients (7.99 ± 0.35 pg/ml) (<i>p</i>-value &lt; 0.001) than in the healthy group (4.24 ± 0.27 pg/ml). Using qPCR and measuring disease severity, the relationship between cytokine gene expression and insulin resistance was assessed. The positive associations between TNF-α, IL-6, vitamin D deficiency, poor glycaemic control, and other disease conditions reflect a fundamental pathophysiological mechanism in insulin resistance in DM patients. This ultimately leads to increased inflammation and tissue damage, worsening the complications of diabetes.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Correlation of TNF-α and IL-6 expression with vitamin D levels in insulin-resistant type 2 diabetes mellitus patients: exploring the role of vitamin D in inflammation and disease pathogenesis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年9月25日

查看全文
  • Muhammad Razi Ul Islam Hashmi,
  • Sarah Sadiq,
  • Shoaib Naiyar Hashmi,
  • Rumsha Zubair,
  • Huma Shafique,
  • Tayyaba Afsar,
  • Dara Aldisi,
  • Suhail Razak

摘要

Background

Chronic low-grade inflammation is often seen in individuals with insulin resistance, characterised by increased levels of pro-inflammatory cytokines, such as TNF-α (tumour necrosis factor-alpha) and IL-6 (interleukin-6). Insulin resistance (IR) and vitamin D deficiency are increasingly recognised as interconnected metabolic issues. Research indicated that low vitamin D levels may impair insulin sensitivity, while insulin resistance can worsen vitamin D deficiency, creating a vicious cycle. This study aims to explore the relationship between TNF-α and IL-6 expression levels and vitamin D levels in insulin-resistant patients with type 2 diabetes mellitus (DM), and compare them with non-diabetic controls to better understand the role of vitamin D in inflammation, disease development, and progression.

Methods

From a total of 150 participants, 30 were healthy individuals (the control group), and 120 were patients with type II diabetes. The current case-control study compared TNF-α, IL-6 expression levels, and serum vitamin D levels between insulin-resistant patients and non-diabetic controls.

Results

The demographic and clinical variables were statistically significant. The case-to-control ratio was 4:1. Higher levels of TNF-α and IL-6 were found in DM patients compared to non-diabetic controls. Insulin-resistant patients exhibited higher IL-6 levels (5.47 ± 0.30 pg/ml) than healthy participants (2.64 ± 0.83 pg/ml), with p-value < 0.001. Vitamin D levels were significantly lower in DM patients (22.33 ± 11.43 ng/ml) compared to healthy subjects (34.12 ± 2.08 ng/ml), with p-value < 0.001. TNF-α levels were also significantly higher in DM patients (7.99 ± 0.35 pg/ml) (p-value < 0.001) than in the healthy group (4.24 ± 0.27 pg/ml). Using qPCR and measuring disease severity, the relationship between cytokine gene expression and insulin resistance was assessed. The positive associations between TNF-α, IL-6, vitamin D deficiency, poor glycaemic control, and other disease conditions reflect a fundamental pathophysiological mechanism in insulin resistance in DM patients. This ultimately leads to increased inflammation and tissue damage, worsening the complications of diabetes.